[Lys]7[Lys]11-VmCT1-NH2
General Information
DRACP ID DRACP02283
Peptide Name [Lys]7[Lys]11-VmCT1-NH2
Sequence FLGALWKVAKKVF
Sequence Length 13
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Membrane lysis
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | 6.3 µM | MTT assay | 24 h | 1 |
Hemolytic Activity Human erythrocytes: ~0% Hemolytic=3.1 µM
Normal (non-cancerous) Cytotoxicity MCF-10A: Not active up to 25 μM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antimicrobial; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C77H119N17O14
Absent amino acids CDEHIMNPQRSTY
Common amino acids K
Mass 172113
Pl 11.1
Basic residues 3
Acidic residues 0
Hydrophobic residues 9
Net charge 3
Boman Index 1412
Hydrophobicity 93.85
Aliphatic Index 120
Half Life
Mammalian: 1.1 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 5500
Absorbance 280nm 458.33
Polar residues 1
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 31181304
Title The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1
Doi 10.1016/j.ejps.2019.06.006
Year 2019
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_16793